170,000 Patients Supported with Impella® Heart Pumps
With today’s innovative technology, minimally invasive treatment options allow patients to recover the function of their native heart.
Patients and Caregivers
Protected PCI can be a safe treatment option to address severe coronary artery disease or advanced heart failure.
Health Care Professionals
Explore clinical data, educational opportunities and resources regarding the latest breakthroughs in cardiac and respiratory research.
Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients
June 1, 2021
Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin
April 29, 2021